Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Roche to acquire Ignyta for $1.7B
February 2018
SHARING OPTIONS:

BASEL, Switzerland—2017 ended with the news of a definitive merger agreement between Roche and Ignyta Inc., under which Roche will acquire Ignyta for $27 per share in an all-cash transaction, for a total value of $1.7 billion on a fully diluted basis. Per the agreement, Roche will immediately commence a tender offer for all outstanding shares of Ignyta common stock, with the closing of the offer subject to a majority of outstanding shares being tendered to the offer as well as other conditions. For its part, Ignyta will file a recommendation statement with the unanimous recommendation of its board that the company’s shareholders tender their shares to the offer. Once the offer is completed, Roche will acquire all remaining shares at the same price via a second step merger. The transaction is expected to be complete in the first half of this year.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2018 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.